Trump Health Care Plan Expected to Benefit Pharmaceutical Companies
Pharmaceutical companies are cautiously optimistic about their prospects under the new Trump management, following four years of stringent policies under former President Joe Biden. President Donald Trump,who has prioritized lowering healthcare costs for Americans,is expected to take a more business-pleasant approach compared to his predecessor. This shift comes as U.S. patients continue to pay two-to-three … Read more
